The primary objectives of the study are to demonstrate the antimanic efficacy and to assess the safety of flexibly dosed paliperidone extended release ER compared with placebo during 3 weeks of treatment in subjects with Bipolar I Disorder who are experiencing an acute manic or mixed episode
Data and Resources
- A Randomized Double-Blind Active- and Placebo-Controlled Parallel-Group Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone Compared with Flexibly-Dosed Quetiapine and Placebo in the Treatment of...json
The primary objectives of the study are to demonstrate the antimanic...
|Release Date|| |
|Public Access Level|| |